Millennial Scientific has been selected for the BioTools Innovator 2026 Accelerator, joining a cohort of approximately 30 companies chosen from over 550 global applicants. BioTools Innovator is the leading accelerator focused exclusively on life science tools and diagnostics, powered by the MedTech Innovator team. Through this program, we will advance our carbon chromatography media and bioprocess materials platform for next-generation biologics manufacturing.

RNA therapeutics require characterization of up to 20 critical quality attributes, which currently demands multiple dedicated LC methods — reversed-phase, anion-exchange, and size-exclusion — on separate instruments. Carbon-based digital liquid chromatography offers a different direction. By applying voltage to an all-carbon conductive stationary phase, retention can be tuned in real time. We explore how this approach may consolidate RNA QC workflows into a single compact pla

Millennial Scientific is advancing NanoPak‑C, a 3D‑printed monolith platform designed to improve biologics chromatography. Supported by an NIH SBIR Phase I project and Empire State Development’s NYSTAR Innovation Matching Grants Program, this work helps bridge the gap between R&D and commercialization, enabling scalable, customizable separation media for more efficient bioprocessing.